A new non-dilution rapid desensitization protocol successfully applied to all-grade platinum hypersensitivity
Chung, Soo Jie, Kang, Sung-Yoon, Kang, Rae-Young, Kim, Young-Chan, Lee, Kyung-Hun, Kim, Tae-Yong, Han, Sae-Won, Kang, Hye-Ryun
Published in Cancer chemotherapy and pharmacology (01.11.2018)
Published in Cancer chemotherapy and pharmacology (01.11.2018)
Get full text
Journal Article
Safety and clinical activity of 1L atezolizumab + bevacizumab in a phase Ib study in hepatocellular carcinoma (HCC)
Stein, Stacey, Pishvaian, Michael J., Lee, Michael Sangmin, Lee, Kyung-Hun, Hernandez, Sairy, Kwan, Antonia, Liu, Bo, Grossman, William, Iizuka, Koho, Ryoo, Baek-Yeol
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Overcoming oxaliplatin hypersensitivity: different strategies are needed according to the severity and previous exposure
Lee, Suh-Young, Kang, Hye-Ryun, Song, Woo-Jung, Lee, Kyung-Hun, Han, Sae-Won, Cho, Sang Heon
Published in Cancer chemotherapy and pharmacology (01.05.2014)
Published in Cancer chemotherapy and pharmacology (01.05.2014)
Get full text
Journal Article
Pharmacogenetic analysis of adjuvant FOLFOX for Korean patients with colon cancer
Lee, Kyung-Hun, Chang, Hye Jung, Han, Sae-Won, Oh, Do-Youn, Im, Seock-Ah, Bang, Yung-Jue, Kim, Sun Young, Lee, Keun-Wook, Kim, Jee Hyun, Hong, Yong Sang, Kim, Tae Won, Park, Young Suk, Kang, Won Ki, Shin, Sang Joon, Ahn, Joong Bae, Kang, Gyeong Hoon, Jeong, Seung-Yong, Park, Kyu Joo, Park, Jae-Gahb, Kim, Tae-You
Published in Cancer chemotherapy and pharmacology (01.04.2013)
Published in Cancer chemotherapy and pharmacology (01.04.2013)
Get full text
Journal Article
A phase I/II trial of second-line chemotherapy with paclitaxel and irinotecan in fluoropyrimidine- and platinum-pretreated patients with advanced gastric cancer
Kim, Jin Won, Choi, In Sil, Kim, Yu Jung, Lee, Kyung-Hun, Lee, Keun-Wook, Kim, Tae-Yong, Han, Sae-Won, Kim, Jee Hyun, Kim, Tae-You, Lee, Jong Seok, Bang, Yung-Jue, Im, Seock-Ah, Oh, Do-Youn
Published in Cancer chemotherapy and pharmacology (01.06.2015)
Published in Cancer chemotherapy and pharmacology (01.06.2015)
Get full text
Journal Article
HER2/CEP17 ratio and HER2 immunohistochemistry predict clinical outcome after first-line trastuzumab plus taxane chemotherapy in patients with HER2 fluorescence in situ hybridization-positive metastatic breast cancer
Kim, Ji-Won, Kim, Jee Hyun, Im, Seock-Ah, Kim, Yu Jung, Han, Hye-Suk, Kim, Jin-Soo, Lee, Kyung-Hun, Kim, Tae-Yong, Han, Sae-Won, Jeon, Yoon Kyung, Oh, Do-Youn, Kim, Tae-You, Park, In Ae
Published in Cancer chemotherapy and pharmacology (01.07.2013)
Published in Cancer chemotherapy and pharmacology (01.07.2013)
Get full text
Journal Article
Differing effects of adjuvant chemotherapy according to BRCA1 nuclear expression in gastric cancer
Kim, Jin Won, Cho, Hyun Jin, Kim, Miso, Lee, Kyung-Hun, Kim, Min A., Han, Sae-Won, Oh, Do-Youn, Lee, Hyuk-Joon, Im, Seock-Ah, Kim, Tae-You, Yang, Han-Kwang, Kim, Woo Ho, Bang, Yung-Jue
Published in Cancer chemotherapy and pharmacology (01.06.2013)
Published in Cancer chemotherapy and pharmacology (01.06.2013)
Get full text
Journal Article
Phase II trial of gemcitabine plus UFT as salvage treatment in oxaliplatin, irinotecan and fluoropyrimidine-refractory metastatic colorectal cancer
Lee, Keun-Wook, Kim, Yu Jung, Lee, Kyung-Hun, Han, Sae-Won, Kim, Tae-Yong, Oh, Do-Youn, Im, Seock-Ah, Kim, Tae-You, Bang, Yung-Jue, Choi, In Sil, Kim, Jee Hyun
Published in Cancer chemotherapy and pharmacology (01.09.2014)
Published in Cancer chemotherapy and pharmacology (01.09.2014)
Get full text
Journal Article
Intron 1 CA dinucleotide repeat polymorphism and mutations of epidermal growth factor receptor and gefitinib responsiveness in non-small-cell lung cancer
Han, Sae-Won, Jeon, Yoon Kyung, Lee, Kyung-Hun, Keam, Bhumsuk, Hwang, Pil Gyu, Oh, Do-Youn, Lee, Se-Hoon, Kim, Dong-Wan, Im, Seock-Ah, Chung, Doo Hyun, Heo, Dae Seog, Bang, Yung-Jue, Kim, Tae-You
Published in Pharmacogenetics and genomics (01.05.2007)
Published in Pharmacogenetics and genomics (01.05.2007)
Get more information
Journal Article
Serum epidermal growth factor is associated with prognosis and hormone receptor status in patients with HER2-positive metastatic breast cancer treated with first-line trastuzumab plus taxane chemotherapy
Kim, Ji-Won, Kim, Jee Hyun, Im, Seock-Ah, Lee, Kyung-Hun, Kim, Jin-Soo, Kim, Tae-Yong, Han, Sae-Won, Jeon, Yoon Kyung, Oh, Do-Youn, Kim, Tae-You, Park, In Ae
Published in Cancer chemotherapy and pharmacology (01.11.2013)
Published in Cancer chemotherapy and pharmacology (01.11.2013)
Get full text
Journal Article
Efficacy of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (iFAM) in the treatment of patients with gemcitabine-pretreated pancreatic cancer and analysis of prognostic factors in a salvage setting
Lim, Kyu-Hyoung, Kim, Tae-Yong, Lee, Kyung-Hun, Han, Sae-Won, Oh, Do-Youn, Im, Seock-Ah, Kim, Tae-You, Bang, Yung-Jue
Published in Cancer chemotherapy and pharmacology (01.10.2011)
Published in Cancer chemotherapy and pharmacology (01.10.2011)
Get full text
Journal Article
Survival outcomes of young patients under 40 with breast cancer in Asian countries according to subtype: An international multicenter cohort study
Kim, Jinyong, Lee, Kyung-Hun, Park, Yeon Hee, Lin, Ching-Hung, Lu, Yen-Shen, Ueno, Takayuki, Yap, Yoon Sim, Yeo, Winnie, Liu, Qiang, Leung, Roland Ching-Yu, Naito, Yoichi, Li, Huiping, Lee, Han-Byoel, Han, Wonshik, Im, Seock-Ah
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Health-related quality of life in patients treated with gemcitabine/cisplatin and durvalumab ± tremelimumab in chemotherapy-naïve advanced biliary tract cancer
Kim, Jin Won, Yoon, Jeesun, Lee, Kyung-Hun, Lee, Dae-Won, Bang, Ju-Hee, Nam, Ah-Rong, Oh, Kyoung-Seok, Kim, Jae-Min, Kim, Tae-Yong, Oh, Do-Youn
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Palbociclib (P) plus tamoxifen (TAM) ± goserelin in women with hormone receptor-positive (HR+)/HER2-negative (HER2−) advanced breast cancer (ABC): Primary results of NCCH1607/PATHWAY, an Asian international double-blind randomized phase 3 trial
Kogawa, Takahiro, Noguchi, Emi, Yamanaka, Takashi, Yamamoto, Naohito, Chung, Chi-Feng, Lu, Yen-Shen, Chang, Dwan-Ying, Sohn, Joohyuk, Kim, Gun Min, Lee, Kyung-Hun, Lee, Soo-Chin, Yap, Yoon Sim, Umeyama, Yoshiko, Sudo, Kazuki, Hata, Tomomi, Kuchiba, Aya, Shibata, Taro, Nakamura, Kenichi, Tamura, Kenji, Yonemori, Kan
Published in Journal of clinical oncology (10.06.2023)
Published in Journal of clinical oncology (10.06.2023)
Get full text
Journal Article
The metabolic activity assessed by 18 F-FDG PET and its correlation with tumor immune status and prognosis in advanced biliary tract cancer patients treated with 1L GemCis plus durvalumab +/-tremelimumab
Yoon, Jeesun, Sung, Hyunpil, Lee, Kyung-Hun, Kim, Jin Won, Lee, Dae-Won, Kim, Tae-Yong, Bang, Ju-Hee, Nam, Ah-Rong, Oh, Kyoung-Seok, Kim, Jae-Min, Jeong, Yoojin, Choo, Sea Young, Kim, Hyo Jung, Lee, Su In, Cheon, Gi Jeong, Oh, Do-Youn
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Characterization of long-term responders following treatment with talazoparib (TALA) or physician’s choice of chemotherapy (PCT) in the phase 3 embraca trial
Ettl, Johannes, Rugo, Hope S., Hurvitz, Sara A., Martin, Miguel, Roche, Henri, Lee, Kyung-Hun, Goodwin, Annabel, Usari, Tiziana, Lanzalone, Silvana, Guenzel, Carolin, Blum, Joanne Lorraine, Litton, Jennifer Keating
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Clinical outcomes in patients (pts) with a history of central nervous system (CNS) metastases receiving talazoparib (TALA) or physician’s choice of chemotherapy (PCT) in the phase 3 EMBRACA trial
Litton, Jennifer Keating, Ettl, Johannes, Hurvitz, Sara A., Martin, Miguel, Roche, Henri, Lee, Kyung-Hun, Goodwin, Annabel, Usari, Tiziana, Lanzalone, Silvana, Guenzel, Carolin, Blum, Joanne Lorraine, Rugo, Hope S.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
A phase IB/II study of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer (KCSG BR18-16)
Kim, Se Hyun, Suh, Koung Jin, Im, Seock-Ah, Lee, Kyung-Hun, Kim, Min Hwan, Sohn, Joohyuk, Park, Yeon Hee, Kim, Ji-Yeon, Jeong, Jae Ho, Lee, Kyoung Eun, Choi, In Sil, Park, Kyong Hwa, Kim, Hee Jun, Cho, Eun Kyung, Park, So Yeon, Kim, Milim, Kim, Jee Hyun
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
The prognostic role of soluble transforming growth factor-β related with soluble programmed death-ligand 1 in biliary tract cancer
Kim, Jin Won, Ha, Hyerim, Lee, Kyung-Hun, Nam, Ah-Rong, Bang, Ju-Hee, Jin, Mei Hua, Oh, Kyoung Seok, Bang, Yung-Jue, Oh, Do-Youn
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
The prognostic role of soluble transforming growth factor-β (sTGFb) and soluble programmed death-ligand 1 (sPDL1) in biliary tract cancer patients treated with binimetinib and capecitabine
Kim, Jin Won, Lee, Kyung-Hun, Kim, Ji-Won, Suh, Koung Jin, Nam, Ah-Rong, Bang, Ju-Hee, Bang, Yung-Jue, Oh, Do-Youn
Published in Journal of clinical oncology (01.02.2019)
Published in Journal of clinical oncology (01.02.2019)
Get full text
Journal Article